Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines
2007 StandoutNobel
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Side effects of therapy of hepatitis C and their management
2002
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
The changing epidemiology of lung cancer in Europe
2003
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Diagnosis, management, and treatment of hepatitis C†
2004
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
QuPath: Open source software for digital pathology image analysis
2017 Standout
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
2010
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Neurologic disorders in 432 consecutive patients with small cell lung carcinoma
2004
Cushing's syndrome
2015 Standout
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
2012 Standout
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small‐molecule screening and structural databases
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Development of a biosensor-based method for detection and isotyping of antibody responses to adenoviral-based gene therapy vectors
2002
Brain metastases: current management and new developments
2008
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
2011
Cytogenetic and molecular aspects of lung cancer
2005
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
2002
Management of the febrile neutropenic cancer patient: lessons from 40 years of study
2005
One mouse, one patient paradigm: New avatars of personalized cancer therapy
2013
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
MicroRNA signatures in human cancers
2006 Standout
TP53 Mutations in Nonsmall Cell Lung Cancer
2011
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
2009
Primer: an evidence-based approach to prognostic markers
2005
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
2011 Standout
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
A typology of reviews: an analysis of 14 review types and associated methodologies
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Side effects of therapy of hepatitis C and their management
2002
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled Trials
2005
Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates.
2008
Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
2007
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
2008 StandoutNobel
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
2016 StandoutNobel
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer
2007
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 Standout
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Assessing Bias in Studies of Prognostic Factors
2013 Standout
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis
2010
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults
2015 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Frédéric Vallot being referenced
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
2003
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients
2002
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
2001
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
2001